Repligen Corporation is a life sciences company focused on the development, production and commercialization of products used in the process of manufacturing biological drugs. Our bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. We are a leading manufacturer of Protein A, a critical reagent used to manufacture monoclonal antibody-based therapeutics. We also supply several growth factor products used to increase cell culture productivity in biomanufacturing. In the burgeoning area of disposable biomanufacturing technologies, we have developed and market a series of OPUS™ (Open Platform User Specified) single-use chromatography columns used in the biologics purification process. Repligen’s corporate headquarters are located in Waltham, MA, USA; we have an additional manufacturing facility in Lund, Sweden.
Waltham, US
168 (est)+24%
Repligen was founded in 1981 and is headquartered in Waltham, US

Key People at Repligen

William J. Kelly

William J. Kelly

Walter C. Herlihy

Walter C. Herlihy

President and CEO
Greg Zarbis-Papastoitsis

Greg Zarbis-Papastoitsis

Team Member

Repligen Locations

Waltham, US
Lund, SE

Repligen Metrics

Repligen Summary

Market capitalization

$1.09 B

Closing share price

Repligen's latest market capitalization is $1.09 B.

Repligen Market Value History

Repligen Company Life

You may also be interested in